[Federal Register Volume 65, Number 54 (Monday, March 20, 2000)]
[Notices]
[Pages 14982-14983]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-6800]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Clinical Laboratory Improvement Advisory Committee (CLIAC): 
Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following committee meetings.

    Name: Clinical Laboratory Improvement Advisory Committee 
(CLIAC).
    Times And Dates: 8:30-5 p.m., April 5, 2000; 8:30 a.m.-3:30 
p.m., April 6, 2000.
    Place: CDC, Koger Center, Williams Building, Conference Rooms 
1802 and 1805, 2877 Brandywine Road, Atlanta, Georgia 30341.
    Status: Open to the public, limited only by the space available. 
The meeting rooms accommodate approximately 85 people.
    Purpose: This committee is charged with providing scientific and 
technical advice and guidance to the Secretary of Health and Human 
Services, the Assistant Secretary for Health, and the Director, CDC, 
regarding the need for, and the nature of, revisions to the 
standards under which clinical laboratories are regulated; the 
impact of proposed revisions to the standards; and the modification 
of the standards to accommodate technological advances.
    Matters To Be Discussed: The agenda will include discussion on 
specimens and test systems not currently regulated under Clinical 
Laboratory Improvement Amendments (CLIA), current and future 
research related to CLIA, and introduction to proficiency testing 
issues.
    The Committee solicits oral and written testimony on all three 
areas cited in the matters to be discussed above. Requests to make 
an oral presentation should be submitted in writing to the contact 
person listed below by close of business, March 29, 2000. All 
requests to make oral comments should contain the name, address, 
telephone number, and organizational affiliation of the presenter. 
Written comments should not exceed five single-spaced typed pages in 
length and should be received by the contact person listed below by 
close of business, March 29, 2000.
    Agenda items are subject to change as priorities dictate.
    Contact Person for Additional Information: Devery Howerton, 
Chief, Laboratory Practice Standards Branch, Division of Laboratory 
Systems, Public Health Practice Program Office, CDC, 4770 Buford 
Highway, NE, Mailstop F-11, Atlanta, Georgia 30341-3724, telephone 
770/488-8044, FAX 770/488-8279.
    The Director, Management Analysis and Services Office has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and ATSDR.

[[Page 14983]]


    Dated: March 14, 2000.
Carolyn J. Russell,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention (CDC).
[FR Doc. 00-6800 Filed 3-17-00; 8:45 am]
BILLING CODE 4163-18-P